ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

News

In The News Seasoned Healthcare Marketing Executive Joins ADVI As Head of Marketing
In The News ADVI Health Welcomes Policy & Reimbursement Expert Brenna Raines
In The News ADVI Expert Speaks With Modern Healthcare About What the IRA Means for PBMs
In The News ADVI Discusses Implications of New Drug Price Bill with Bloomberg Law
In The News ADVI’s Lindsay Bealor Greenleaf told BioWorld that whether the launch interchangeable insulin biosimilars will result in lower costs for patients will be decided by PBMs.
In The News ADVI’s Lindsay Bealor Greenleaf spoke to BioWorld about the latest congressional scrutiny around prescription drug list price increases and the overlooked role played by pharmacy benefit managers.
In The News ADVI’s Lindsay Bealor Greenleaf spoke to AISHealth about CMS’ recent proposal to rein in pharmacy price concessions imposed by pharmacy benefit managers
In The News ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about a new report on PBMs & their ability to manufacture profits at the expense of patients.
In The News The House passed the Build Back Better reconciliation bill on Friday, which includes authorization for the government to negotiate lower drug prices. ADVI Health’s Lindsay Bealor Greenleaf shared insights on the measure with Pharmacy Times

Posts pagination

< Previous page 1 … 9 10 11 … 25 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health